These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23721110)

  • 41. [Data transparency regarding medical devices - the position of the medical device industry].
    Soskuty G
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(3):189-93. PubMed ID: 21530908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Financing development stage biotechnology companies: RMs vs. IPOs.
    Ahn MJ; Couch RB; Wu W
    J Health Care Finance; 2011; 38(1):32-54. PubMed ID: 22043645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Health technology diffusion in developing countries: a case study of CT scanners in Brazil.
    Silva HP; Viana AL
    Health Policy Plan; 2011 Sep; 26(5):385-94. PubMed ID: 21118866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Small company mergers--good for whom?
    Maybeck V; Bains W
    Nat Biotechnol; 2006 Nov; 24(11):1343-8. PubMed ID: 17093475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [From idea to standard care-a field report].
    Herberz C; Steidl R; Werner P; Hagen J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Mar; 61(3):298-303. PubMed ID: 29383393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Digital Transformation and Disruption of the Health Care Sector: Internet-Based Observational Study.
    Herrmann M; Boehme P; Mondritzki T; Ehlers JP; Kavadias S; Truebel H
    J Med Internet Res; 2018 Mar; 20(3):e104. PubMed ID: 29588274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Development of Human Health Discoveries. 10 years results of Young Innovative Company incubation].
    Marsac J
    Bull Acad Natl Med; 2014; 198(4-5):905-16. PubMed ID: 26753415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Health professionals' views on health literacy issues for culturally and linguistically diverse women in maternity care: barriers, enablers and the need for an integrated approach.
    Hughson JA; Marshall F; Daly JO; Woodward-Kron R; Hajek J; Story D
    Aust Health Rev; 2018 Feb; 42(1):10-20. PubMed ID: 29081348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Indian biotechnology--rapidly evolving and industry led.
    Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682
    [No Abstract]   [Full Text] [Related]  

  • 52. Exploitation of biotechnology in a smaller company.
    Fairtlough GH
    Philos Trans R Soc Lond B Biol Sci; 1989 Aug; 324(1224):589-97. PubMed ID: 2573092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Testing times: trends in availability, price, and market share of malaria diagnostics in the public and private healthcare sector across eight sub-Saharan African countries from 2009 to 2015.
    ; Hanson K; Goodman C
    Malar J; 2017 May; 16(1):205. PubMed ID: 28526075
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defining next-generation products: an inside look.
    Tabrizi B; Walleigh R
    Harv Bus Rev; 1997; 75(6):116-24. PubMed ID: 10174793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. "Public health is global": examining Indian stakeholders' perspectives on Global Health education.
    Sawleshwarkar S; Zodpey S; Negin J
    BMC Public Health; 2020 Aug; 20(1):1259. PubMed ID: 32811469
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Wall Street's assessment of plastic surgery--related technology: a clinical and financial analysis.
    Krieger LM; Shaw WW
    Plast Reconstr Surg; 2000 Feb; 105(2):609-16. PubMed ID: 10697168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of Health Care Reform on Technology and Innovation.
    Kesavan P; Dy CJ
    Hand Clin; 2020 May; 36(2):255-262. PubMed ID: 32307056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Translational science by public biotechnology companies in the IPO "class of 2000": the impact of technological maturity.
    McNamee L; Ledley F
    PLoS One; 2013; 8(12):e82195. PubMed ID: 24358154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes of Australian rural clinical schools: a decade of success building the rural medical workforce through the education and training continuum.
    Greenhill JA; Walker J; Playford D
    Rural Remote Health; 2015; 15(3):2991. PubMed ID: 26377746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Business Ethics 101 for the biotech industry.
    MacDonald C
    BioDrugs; 2004; 18(2):71-7. PubMed ID: 15046523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.